EphA2-targeted alpha-particle theranostics for enhancing PDAC treatment is a research paper published in Theranostics (2025). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3P30CA006973-53S2
Regional Oncology Research Center
National Institutes of Health
Grant: 5R01CA269235-02
Clinical translation of a PD-L1 PET tracer to optimize immune checkpoint therapy in patients with non-small cell lung cancers
National Institutes of Health
Grant: 5R01CA236616-05
Non-invasive Quantification of Dose-Exposure-Response of PD-L1 Therapeutics at the Tumor
FWCI
8.18
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords